BRAF and melanoma: Interestingly, a study conducted in a PDX model of BRAF mutant melanoma demonstrated that NCSC depletion from MRD prevented the development of non‐genetic mechanisms of acquired resistance, leaving persistent cells dependent on de novo genetic mechanisms.17